Volume 10,Issue 3
The European Institute for Innovation through Health Data (i~HD) has been formed as one of the sustainable entities arising from the Electronic Health Records for Clinical Research (EHR4CR) and SemanticHealthNet projects, in collaboration with other European Commission projects and initiatives. The vision of i~HD is to become the European organisation of reference for guiding and catalysing the best, most efficient and trustworthy uses of health data and interoperability, for optimizing health and knowledge discovery.
i~HD has been established in recognition that there is a need to tackle areas of challenge in the successful scaling up of innovations that rely on high-quality and interoperable health data, to sustain and propagate the results of eHealth research, and to address current-day obstacles to using health data. i~HD was launched at an inaugural conference in Paris, in March 2016. This was attended by over 200 European clinicians, healthcare providers and researchers, representatives of the pharma industry, patient associations, health professional associations, the health ICT industry and standards bodies. The event showcased issues and approaches, that are presented in this paper to highlight the activities that i~HD intends to pursue as enablers of the better uses of health data, for care and research.
1. Adoption of Electronic Health Record Systems among U.S. Non-Federal Acute Care Hospitals: 2008-2015. ONC Data Brief 35, May, 2016, viewed 8 September, 2016. http://dashboard.healthit.gov/evaluations/data-briefs/non-federal-acute-care-hospital-ehr-adoption-2008-2015.php
2. Jha A K, Doolan D, Grandt D, et al. 2008, The use of health information technology in seven nations. International Journal of Medical Informatics, 77 (12): 848–54. https://doi.org/10.1016/j.ijmedinf.2008.06.007
3. Kalra D, 2011, Health informatics 3.0. Yearbook of Medical Informatics, 6 (1): 8–14.
4. Kalra D, 2015, Big Data: Opportunities for Healthcare Organisations. HealthManagement.org, 25 (4): 302– 303.
5. Medication Error Reports, n.d., viewed 8 September, 2016. http://www.fda.gov/Drugs/DrugSafety/MedicationErrors/ucm080629.htm
6. Sertkaya A, Birkenbach A, Berlind A, et al. 2014, Examination of Clinical Trial Costs and Barriers for Drug Development. Eastern Research Group Inc., Lexington, MA 02421, viewed 8 September, 2016. https://aspe.hhs.gov/sites/default/files/pdf/77166/rpt_erg.pdf
7. De Moor G, Sundgren M, Kalra D, et al. 2015, Using electronic health records for clinical research: The case of the EHR4CR project. Journal of Biomedical Informatics, 53: 162–173. https://doi.org/10.1016/j.jbi.2014.10.006
8. Beresniak A, Schmidt A, Proeve J, et al. 2016, Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project. Contemporary clinical trials, 46: 85–91. https://doi.org/10.1016/j.cct.2015.11.011
9. Achey M A, Beck C A, Beran D B, et al. 2015, A randomized controlled trial of telemedicine for Parkinson disease (Connect. Parkinson) in the United States: Interim assessment of investigator and participant experiences. Movement Disorders, 30: S64–S64.
10. Groves P, Kayyali B, Knott D, et al. 2013, The Big Data Revolution in Healthcare. Center for US Health System Reform, Business Technology Office, McKinsey and Co. 2013, viewed 8 September, 2016. http://www.mckinsey.com/~/media/mckinsey/industries/healthcare%20systems%20and%20services/our%20insights/%20the%20big%20data%20revolution%20in%20us%20healt%20care/the_big_data_revolution_in_healthcare.ashx
11. van Staa T P, Ben G, Iain B, et al. 2016, Big health data: The need to earn public trust. BMJ, 354: i3636
12. Kalra D, Stroetmann V, Sundgren M, et al. 2016, The European Institute for Innovation through Health Data. Learning Health Systems, 1: 1–8. http://dx.doi.org/10.1002/lrh2.10008
13. Coorevits P, Sundgren M, Klein G O, et al. 2013, Electronic health records: New opportunities for clinical research. J Intern Med, 274(6): 547–60. http://dx.doi.org/10.1111/joim.12119
14. Beresniak A, Schmidt A, Dupont D, et al. Improving Performance of Clinical Research: Development and Interest of Electronic Health Records. BioMed Research International, 2015: 864549. http://dx.doi.org/10.1155/2015/864549
15. Custodix N V, n.d., viewed 8 September, 2016. https://www.custodix.com
16. The InSite Platform, n.d., viewed 8 September, 2016. www.insiteplatform.com
17. The Innovative Medicines Initiative 2016, n.d., viewed 8 September, 2016. http://www.imi.europa.eu
18. Bahr A and SchlünderI, 2015, Code of practice on secondary use of medical data in European scientific research projects. International Data Privacy Law, 5(4): 279–291. http://dx.doi.org/10.1093/idpl/ipv018
19. Interoperability & standardisation: connecting eHealth services, n.d., viewed 8 September, 2016. https://ec.europa.eu/digital-single-market/en/interoperability-standardisation-connecting-ehealth-services
20. A Digital Single Market Strategy for Europe, n.d., viewed 8 September, 2016. http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1447773803386&uri=CELEX:52015DC0192
21. Public Services, n.d., viewed 8 September, 2016. https://ec.europa.eu/digital-single-market/en/public-services-egovernment
22. Guidelines On Minimum/Non-Exhaustive Patient Summary Dataset For Electronic Exchange In Accordance With The Cross-Border Directive 2011/24/EU, viewed 8 September, 2016. http://ec.europa.eu/health/ehealth/docs/guidelines_patient_summary_en.pdf
23. Guidelines On ePrescriptions Dataset For Electronic Exchange Under Cross-Border Directive 2011/24/EU, viewed 8 September, 2016. http://ec.europa.eu/health/ehealth/docs/eprescription_guidelines_en.pdf
24. Putting patients in the driving seat: A digital future for healthcare, n.d., viewed 8 September, 2016. https://ec.europa.eu/digital-single-market/en/news/putting-patients-driving-seat-digital-future-healthcare
25. eHealth Network, n.d., viewed 8 September, 2016. http://ec.europa.eu/health/ehealth/policy/network/index_en.htm
26. Commission Decision (EU) 2015/1302 of 28 July 2015 on the identification of ‘Integrating the Healthcare Enterprise’ profiles for referencing in public procurement, viewed 8 September, 2016. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:JOL_2015_199_R_0011
27. Horizon 2020 Work Programme 2016 – 2017, viewed 8 September, 2016. http://ec.europa.eu/research/participants/data/ref/h2020/wp/2016_2017/main/h2020-wp1617-health_en.pdf
28. Transatlantic Cooperation, n.d., viewed 8 September, 2016. https://ec.europa.eu/digital-single-market/en/transatlantic-cooperation
29. Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare, viewed 8 September, 2016. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32011L0024
30. Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23 July 2014 on electronic identification and trust services for electronic transactions in the internal market and repealing Directive 1999/ 93/EC, viewed 8 September, 2016. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2014.257.01.0073.01.ENG
31. The Directive on security of network and information systems, n.d., viewed 8 September, 2016. https://ec.europa.eu/digital-single-market/en/news/network-and-information-security-nis-directive
32. Current initiatives to unlock the potential of mobile health in Europe, n.d., viewed 8 September, 2016. https://ec.europa.eu/digital-single-market/en/news/current-initiatives-unlock-potential-mobile-health-europe
33. Osborne S, Radnor Z and Strokosch K, 2016, Co-Production and the Co-Creation of Value in Public Services: A suitable case for treatment? Public Management Review, 18 (5): 639–653. http://dx.doi.org/10.1080/14719037.2015.1111927
34. Janamian T, Crossland L and Wells L, 2016, On the road to value co-creation in health care: The role of consumers in defining the destination, planning the journey and sharing the drive. The Medical Journal of Australia, 204(7 Suppl): S12–S14. http://dx.doi.org/10.5694/mja16.00123